A detailed history of Ar Asset Management Inc transactions in Marker Therapeutics, Inc. stock. As of the latest transaction made, Ar Asset Management Inc holds 70,700 shares of MRKR stock, worth $251,692. This represents 0.09% of its overall portfolio holdings.

Number of Shares
70,700
Previous 70,700 -0.0%
Holding current value
$251,692
Previous $304,000 26.32%
% of portfolio
0.09%
Previous 0.07%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 03, 2023

BUY
$3.59 - $8.78 $107,700 - $263,400
30,000 Added 73.71%
70,700 $321,000
Q1 2023

May 09, 2023

BUY
$0.28 - $3.12 $11,396 - $126,984
40,700 New
40,700 $29,000
Q1 2022

May 10, 2022

BUY
$0.37 - $1.0 $76,775 - $207,500
207,500 Added 290.21%
279,000 $123,000
Q4 2021

Feb 07, 2022

SELL
$0.95 - $1.72 $197,125 - $356,900
-207,500 Reduced 74.37%
71,500 $68,000
Q3 2021

Nov 04, 2021

SELL
$1.68 - $2.88 $1,680 - $2,880
-1,000 Reduced 0.36%
279,000 $472,000
Q2 2021

Aug 04, 2021

BUY
$1.88 - $3.56 $526,400 - $996,800
280,000 New
280,000 $781,000

Others Institutions Holding MRKR

About Marker Therapeutics, Inc.


  • Ticker MRKR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,599,200
  • Market Cap $298M
  • Description
  • Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...
More about MRKR
Track This Portfolio

Track Ar Asset Management Inc Portfolio

Follow Ar Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ar Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ar Asset Management Inc with notifications on news.